Skip to content

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

ICAAC: Moxifloxacin could cut TB treatment time to four months

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort

European researchers develop method of calculating short-term risk of HIV disease progression

Mantoux test good predictor of HIV-positive women's response to HPV

Condoms, not serosorting explain stable HIV incidence in 'lower risk' Amsterdan gay men

CD4 cell loss not enough to cause AIDS in some monkeys